image
BioMarin Pharmaceutical Inc. BMRN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 70.925
-0.33 %
$ 13.5 B
Market Cap
32.09
P/E
INCOME STATEMENT
2.85 B REVENUE
17.97%
Growth Rates
1Year 17.97%
3Years 15.62%
5Years 10.86%
7Years 11.72%
10Years 14.28%
484 M OPERATING INCOME
149.03%
Growth Rates
1Year 149.03%
3Years 115.93%
5Years 42.42%
7Years 66.14%
10Years 21.85%
427 M NET INCOME
154.62%
Growth Rates
1Year 154.62%
3Years 105.37%
5Years 81.87%
7Years 28.06%
10Years 17.89%
EFFICIENCY
Earnings Waterfall BioMarin Pharmaceutical Inc.
image
Revenue 2.85 B
Cost Of Revenue 580 M
Gross Profit 2.27 B
Operating Expenses 1.79 B
Operating Income 484 M
Other Expenses 57.4 M
Net Income 427 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998
REVENUE
Revenue 2 853.9 2 419.2 2 096.0 1 846.3 1 860.5 1 704.0 1 491.2 1 313.6 1 116.9 889.9 751.0 548.5 500.7 441.4 376.3 324.7 296.5 121.6 84.2 25.7 18.6 12.1 13.9 11.7 12.3 7.0 1.2
GROSS PROFIT
Cost Of Revenue 580.2 577.1 483.7 470.5 524.3 359.5 315.3 241.8 209.6 152.0 129.8 95.7 91.8 84.0 70.3 65.9 52.5 18.4 8.7 2.6 4.0 0 0 0 (6.6) (6.1) (0.7)
Gross Profit 2 273.7 1 842.2 1 612.4 1 375.8 1 336.2 1 344.6 1 175.9 1 071.9 907.2 737.9 621.3 452.7 408.9 357.3 306.0 258.7 244.0 103.2 75.5 23.0 14.7 12.1 13.9 11.7 18.9 13.1 1.9
OPERATING INCOME
Operating Expenses 1 789.5 1 746.3 1 570.8 1 458.1 1 432.4 1 470.0 1 349.5 1 211.6 1 111.5 1 019.4 781.7 608.8 519.1 389.8 299.0 242.3 204.2 160.5 100.1 87.3 162.6 87.9 81.5 52.0 51.9 40.6 14.8
Selling, General and Administrative Expenses 1 009.0 937.3 854.0 759.4 737.7 680.9 604.4 554.3 476.6 402.3 302.2 235.4 198.2 175.4 151.7 124.3 106.6 77.5 49.0 41.6 37.6 14.4 17.5 6.7 8.8 6.8 3.5
Research and Development Expenses 747.2 746.8 649.6 628.8 628.1 715.0 696.3 610.8 661.9 634.8 461.5 354.8 302.2 214.4 147.3 115.1 93.3 78.6 66.7 56.4 49.8 54.8 54.5 45.3 35.8 27.2 10.5
Operating Income 484.2 194.4 57.5 (60.0) (96.3) (125.5) (123.5) (14.7) (803.4) (110.7) (92.9) (156.0) (110.2) (33.9) 0.5 16.4 39.8 (57.3) (24.7) (64.2) (179.4) (75.8) (78.8) (51.9) (33.0) (27.5) (12.9)
PRE-TAX INCOME
Interest Income Expense (12.7) 17.3 16.0 15.3 29.3 23.5 43.7 42.7 39.5 38.2 36.6 10.4 7.6 8.3 10.3 14.1 16.4 0 16.7 11.9 0 3.1 0 0 7 K 0 0
Total Other Income 57.5 (5.9) 14 K (15.3) (5.6) 5.6 (19.2) (35.9) (27.6) (44.0) (32.0) (20.5) (8.1) (9.7) (22.0) (15.9) (6.3) 42.2 (3.9) (10.1) (8.1) 5 K 1.4 (19.0) (7.3) (3.4) 0.6
Pre-Tax Income 541.8 188.6 149.6 (75.3) (42.3) (94.8) (142.7) (35.9) (831.0) (154.7) (124.9) (176.5) (118.3) (43.6) (21.5) 0.6 33.4 (15.1) (28.5) (74.3) (187.4) (75.8) (77.5) (70.9) (40.3) (29.2) (12.3)
NET INCOME
Tax Provision 114.9 20.9 8.0 (11.3) (901.4) (71.0) (65.5) 81.2 (200.8) 17.1 9.1 (0.1) (3.9) 10.2 (227.3) 1.1 2.6 0.7 23.1 21.9 36.6 5 K 9.8 20.0 4.4 0.6 (0.6)
Net Income 426.9 167.6 141.6 (64.1) 854.0 (23.8) (77.2) (117.0) (630.2) (171.8) (134.0) (176.4) (114.3) (53.8) 205.8 (0.5) 30.8 (15.8) (28.5) (74.3) (187.4) (75.8) (77.5) (67.6) (37.4) (28.1) (12.3)
EPS 2.25 0.89 0.76 0.35 4.75 0.13 0.44 0.67 3.8 1.07 0.92 1.28 0.95 0.48 1.99 0.0049 0.31 0.16 0.34 1.08 2.91 1.22 1.45 1.65 1.04 0.94 0.55